FDA Alerts

FDA
FDA
The FDA and Doctors: Why We Need to Pay Attention
03/23/2015
William H. Eaglstein, MD
I am often surprised that any doctors and medical students miss the mark on what FDA stands for.
03/23/2015
FDA Alerts
FDA Alerts
FDA approves drug for neuroblastoma
03/10/2015
...
03/10/2015
Fungal infections
Fungal infections
FDA Approves New Antifungal Drug
03/09/2015
The FDA has announced the approval of a new antifungal drug to treat adults with invasive aspergillosis and invasive mucormycosis.
03/09/2015
Flu
Flu
FDA/WHO Recommend Components for 2015-2016 Flu Vaccine
03/06/2015
The FDA has released its recommendations—based on a report by the WHO—for the vaccine components of next year's trivalent and quadrivalent influenza vaccines.
03/06/2015
Cancer
Cancer
FDA Approves First Biosimilar Product In The US
03/06/2015
The FDA has approved Zarxio (filgrastim-sndz), the first biosimilar product to be released in the United States, for indications including certain patients with cancer, leukemia, and neutropenia.
03/06/2015
testosterone
testosterone
FDA: Testosterone Therapy May Increase CV Risk
03/04/2015
The FDA announced new label requirements for testosterone therapy drugs warning of possible cardiovascular risks.
03/04/2015
FDA
FDA
FDA Approves New Combo Antibacterial Drug
03/02/2015
Researchers approved a new combination drug for the treatment of intra-abdominal and complicated urinary tract infections.
03/02/2015
venous thromboembolism
venous thromboembolism
FDA Approves New System for Varicose Vein Treatment
02/27/2015
The FDA has approved a new option for the treatment of individuals with symptomatic superficial varicose veins of the legs.
02/27/2015
FDA Alerts
FDA Alerts
In landmark FDA tobacco study, e-cig questions likely to linger
02/27/2015
...
02/27/2015
FDA Alerts
FDA Alerts
Long-acting contraceptives work beyond FDA-approved duration
02/10/2015
...
02/10/2015